Harvard Intensive Review of Nephrology 2026

The Comprehensive Clinical Update and Board Review
Intensive Review of Nephrology is an online course, using live streaming, electronic Q&A, and other remote learning technologies.
With over 70 interactive lectures, case discussions, board preparation sessions, and supplementary lectures, this program provides a comprehensive review of state-of-the-art nephrology practices. It offers accelerated learning for:
>> Clinicians seeking a practical and comprehensive review that ensures they are up to date across all major areas of nephrology:

The latest options for diagnosis: what to choose, when, and why
Current evidence-based treatment and care management strategies to optimize patient outcomes
Improved approaches to common and complex clinical challenges
Navigating clinical controversies
How to avoid medical mistakes

>> Physicians preparing to certify or recertify who seek a thorough, proven preparatory course in advance of their taking the Nephrology ABIM board examination:

Daily board review questions and sessions
Sessions to guide efficient preparation and study
Comprehensive syllabus and home study guide

Comprehensive Education
This course spans all areas of nephrology. Sessions are led by experts in their respective fields. Coverage includes:

Electrolytes and Acid-Base
Glomerulonephritis
Acute Kidney Injury
Chronic Kidney Disease
Genetic Kidney Disease
Vascular Disease
Hypertension
End-Stage Renal Disease
Transplantation
Onconephrology: Cancer and the Kidney
Pregnancy and Renal Disease
Point-of-Care Renal Ultrasound

2026 Program Highlights

Genetic testing for improved diagnosis, prognosis, and selection of therapy
Introduction to point-of-care ultrasound: fundamentals for optimal image acquisition and accurate interpretation
Physical exam of the dialysis access
High-dose hemodiafiltration versus high-flux hemodialysis in the management of ESKD
Further expansion of the roles of SGLT2 inhibitors, GLP-1 agonists, and finerenone in diabetic and non-diabetic kidney disease
Novel immunosuppressive agents for glomerulonephritis, including the evolving role of Chimeric Antigen Receptor T-cell therapy (CAR-T)
An introduction to xenotransplantation
The role of renal-dedicated palliative care (“KidneyPal”) in Nephrology and the principles of conservative kidney management
AI in Nephrology

Who Should Participate

Physicians
Nurse Practitioners
Physician Assistants

…and other medical professionals interested in a comprehensive update on state-of-the-art nephrology

+ Topics:
Day 1: Monday, August 10, 2026

8:45-8:50 am: Welcome Remarks/Announcements – Course Directors

8:50-9:35 am: Renal Physiology for the Boards – Dr. Melanie Hoenig

9:35-10:05 am: Basic Concepts of Immunology in Autoimmune Kidney Disease – Dr. Ramon Bonegio

10:05-10:10 am: Faculty Q&A – Drs. Melanie Hoenig and Ramon Bonegio

10:10-10:20 am: Break

10:20-11:05 am: Renal Pathology in 2026: Part 1 – Dr. Helmut Rennke

11:05-11:50 am: Renal Pathology in 2026: Part 2 – Dr. Astrid Weins

11:50 am-12:20 pm: Current Approaches to Urine Sediment Analysis – Dr. Martina McGrath

12:20-12:25 pm: Faculty Q&A – Drs. Astrid Weins, Martina McGrath, and Helmut Rennke

12:25-1:55 pm: Break

1:55-2:40 pm: IgA Nephropathy – Dr. Gerald Appel

2:40-3:10 pm: Metabolic Management of Kidney Stones – Dr. Gary Curhan

3:10-3:55 pm: AI in Nephrology: Clinical Applications – Dr. Navdeep Tangri

3:55-4:00 pm: Faculty Q&A – Drs. Gerald Appel, Gary Curhan, and Navdeep Tangri

4:00-4:15 pm: Break

4:15-5:00 pm: Update on Lupus Nephritis – Dr. Gerald Appel

5:00-5:30 pm: Membranous Nephropathy – Dr. Laurence Beck

5:30-6:15 pm: Anemia Management: Update and Best Practices – Dr. Brona Moloney

6:15-6:25 pm: Faculty Q&A – Drs. Gerald Appel and Laurence Beck

6:25 pm: Adjourn Day 1 Live Program

Self-Paced Study (Pre-recorded sessions):

Glomerulonephritis: Questions & Answers Session – Dr. Gerald Appel

Must-Know Clinical Images in Nephrology – Dr. Annie Liu

Must-Know Board Zebras – Dr. Emily Robinson

Nephrology Board Review Practice 1 – Dr. Finnian Mc Causland

Nephrology Board Review Practice 2 – Dr. Gearoid McMahon

Day 2: Tuesday, August 11, 2026

8:45-8:50 am: Day 2 Announcements – Course Directors

8:50-9:35 am: Acid-Base Disorders I: Anion Gap Metabolic Acidosis – Dr. Alan Yu

9:35-10:35 am: Acid-Base Disorders II: Non-Gap Acidosis and Metabolic Alkalosis – Dr. Alan Yu

10:35-10:45 am: Break

10:45-11:30 am: Hyponatremia and Hypernatremia – Dr. David Mount

11:30 am-12:20 pm: Hypokalemia and Hyperkalemia – Dr. David Mount

12:20-1:50 pm: Break

1:50-2:35 pm: Important New Trials in GN – Dr. David Mount

2:35-3:20 pm: Genetics and Kidney Disease – Dr. Friedhelm Hildebrandt

3:20-4:05 pm: Update on Polycystic Kidney Disease – Dr. Fouad Chebib

4:05-4:10 pm: Faculty Q&A – Drs. David Mount, Friedhelm Hildebrandt, and Fouad Chebib

4:10-4:20 pm: Break

4:20-5:05 pm: Pediatric Nephrology – Dr. Alexis Gomez

5:05-5:50 pm: Genetics: How to Integrate into Practice – Dr. Ana Onuchic-Whitford

5:50-6:20 pm: Rapidly Progressive Glomerulonephritis – Dr. John Niles

6:20-6:35 pm: Faculty Q&A – Drs. Alexis Gomez, Ana Onuchic-Whitford, and John Niles

6:35 pm: Adjourn Day 2 Live Program

Self-Paced Study (Pre-recorded sessions):

Electrolyte and Acid Base Disorders: Questions & Answers Session – Part 1 – Dr. Alan Yu

Electrolyte and Acid Base Disorders: Questions & Answers Session – Part 2 – Dr. Alan Yu

Chronic Kidney Disease in the Community: Meeting Them Where They Are – Dr. Li-Li Hsiao

COVID-19 Vaccine in Immunocompromised Patients – Dr. Ann Woolley

Update on Renovascular Disease – Dr. Joseph Garasic

Day 3: Wednesday, August 12, 2026

8:45-8:50 am: Day 3 Announcements – Course Directors

8:50-9:35 am: Why Do We Reject a Transplant? – Dr. Jamil Azzi

9:35-10:20 am: Transplant Immunosuppression for the Boards – Dr. Kaitlyn Lei

10:20-10:25 am: Faculty Q&A – Drs. Jamil Azzi and Kaitlyn Lei

10:25-10:35 am: Break

10:35-11:20 am: Immunological Assessment Pre- and Post-Transplant – Drs. Melissa Yeung and Indira Guleria

11:20 am-12:05 pm: Early Post-Transplant Management – Dr. Anil Chandraker

12:05-12:10 pm: Faculty Q&A – Drs. Melissa Yeung and Indira Guleria

12:10-1:40 pm: Break

1:40-2:10 pm: Donor Evaluation – Dr. Martina McGrath

2:10-2:40 pm: Late Loss of the Kidney Transplant – Dr. Rania El Fekih

2:40-3:10 pm: Infections in Transplant Recipients – Dr. Barbra Blair

3:10-3:40 pm: Monitoring Kidney Transplant Patients: Beyond Creatinine – Dr. Jamil Azzi

3:40-4:10 pm: Pre-Transplant Evaluation of Recipients – Dr. Rania El Fekih

4:10-4:15 pm: Faculty Q&A – Drs. Martina McGrath, Jamil Azzi, Rania El Fekih, and Barbra Blair

4:15-4:25 pm: Break

4:25-4:55 pm: Thrombotic Microangiopathies – Dr. Jean Francis

4:55-5:25 pm: Late Post-Transplant Medical Complications – Dr. Leonardo Riella

5:25-5:55 pm: KEYNOTE: Xenotransplantation – Dr. Leonardo Riella

5:55-6:25 pm: Geriatric Nephrology – Dr. Ernest Mandel

6:25-6:35 pm: Faculty Q&A – Drs. Jean Francis, Ernest Mandel, and Leonardo Riella

6:35 pm: Adjourn Day 3 Live Program

Self-Paced Study (Pre-recorded sessions):

Pre-Transplant Surgical Evaluation of Recipients – Dr. Sayeed Malek

Immunologic Basis of Kidney Disease – Dr. Vivek Kasinath

Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Dr. Naoka Murakami

Transplant Cases: Board Review – Drs. Melissa Yeung and Edgar Milford

Transplant Board Review – Dr. Anil Chandraker

Poisonings and Intoxications: What a Nephrologist Needs to Know – Dr. Charlotte Goldfine

Day 4: Thursday, August 13, 2026

8:45-8:50 am: Day 4 Announcements – Course Directors

8:50-9:35 am: Cardiorenal Syndrome – Dr. Finnian Mc Causland

9:35-10:20 am: Management of Hypertension in CKD-Intensive or Standard Regimens – Dr. Richard Glassock

10:20-10:25 am: Faculty Q&A – Drs. Richard Glassock and Finnian Mc Causland

10:25-10:35 pm (am): Break (Lưu ý: Thời gian này có thể là am thay vì pm)

10:35-11:20 am: Primary Aldosteronism – Dr. Anand Vaidya

11:20-11:50 am: Therapy of FSGS Lesions in 2026 – Dr. Richard Glassock

11:50 am-12:20 pm: Liver and the Kidney – Dr. Andrew Allegretti

12:20-12:25 pm: Faculty Q&A – Drs. Anand Vaidya, Andrew Allegretti, and Richard Glassock

12:25-1:55 pm: Break

1:55-2:25 pm: Pathophysiology of Acute Kidney Injury – Dr. Joseph Bonventre

2:25-2:55 pm: Acute Kidney Injury Syndromes – Dr. Alice Sheridan

2:55-3:25 pm: ICU Nephrology and Continuous Renal Replacement Therapies – Dr. Andrew Allegretti

3:25-3:30 pm: Faculty Q&A – Drs. Joseph Bonventre, Alice Sheridan, and Andrew Allegretti

3:30-3:40 pm: Break

3:40-4:25 pm: Cancer and Acute Kidney Injury – Dr. Abdullah Jalal

4:25-4:55 pm: Paraprotein-Induced Kidney Injury – Dr. Raad Chowdhury

4:55-5:25 pm: KEYNOTE: Kidney PAL Program – Dr. Samantha Gelfand

5:25-5:55 pm: Pathophysiology and Treatment of Diabetic Kidney Disease – Dr. Gearoid McMahon

5:55-6:40 pm: APOL1 and Kidney Disease – Dr. Opeyemi Olabisi

6:40-6:50 pm: Faculty Q&A – Drs. Samantha Gelfand, Opeyemi Olabisi, Raad Chowdhury, and Gearoid McMahon

6:50 pm: Adjourn Day 4 Live Program

Self-Paced Study (Pre-recorded sessions):

Interstitial Nephritis – Dr. Julie Paik

Ethics – Dr. Kathleen McFadden

Pregnancy and Renal Disease – Dr. Jessica Tangren

Day 5: Friday, August 14, 2026

8:45-8:50 am: Day 5 Announcements – Course Directors

8:50-9:20 am: Patient Perspective: Dialysis Dosing – Dr. John Kevin Tucker

9:20-9:50 am: Hemodiafiltration – Dr. John Kevin Tucker

9:50-10:35 am: Mineral and Bone Disease – Dr. David Bushinsky

10:35-10:40 am: Faculty Q&A – Drs. David Bushinsky and John Kevin Tucker

10:40-10:50 am: Break

10:50-11:35 am: Dialysis: A Case-Based Clinical Review and Update – Dr. John Kevin Tucker

11:35 am-12:20 pm: Pearls in Mineral and Bone Disease – Dr. David Bushinsky

12:20-12:50 pm: Chronic Kidney Disease Epidemiology: A 2026 Update – Dr. Gearoid McMahon

12:50-12:55 pm: Faculty Q&A – Drs. Gearoid McMahon, David Bushinsky and John Kevin Tucker

12:55-2:25 pm: Break

2:25-3:10 pm: Peritoneal Dialysis – Dr. Joanne Bargman

3:10-3:55 pm: Peritoneal Dialysis Complications – Dr. Joanne Bargman

3:55-4:25 pm: Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Dr. Shruti Gupta

4:25-4:30 pm: Faculty Q&A – Drs. Joanne Bargman and Shruti Gupta

4:30-4:40 pm: Break

4:40-5:10 pm: Mesoamerican Nephropathy – Dr. David Friedman

5:10-5:40 pm: Ultrasound for the Clinical Nephrologist – Dr. Adina Voiculescu

5:40-6:25 pm: Dialysis Vascular Access: Assessment and Complications – Dr. Dirk Hentschel

6:25-6:35 pm: Faculty Q&A – Drs. Adina Voiculescu, Dirk Hentschel, and David Friedman

6:35-6:40 pm: Closing Remarks